Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (38)
Elisa Souza Vaz, Sandra Valeria Vassiliades, Jeanine Giarolla, Michelle Carneiro Polli & Roberto Parise-Filho. (2023) Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies. European Journal of Clinical Pharmacology 79:6, pages 723-751.
Crossref
Crossref
Angelena Lopez, Yuri Matusov, Isabel Pedraza, Victor Tapson, Jeremy Falk & Peter Chen. 2023. Coronavirus Disease 2019 (COVID‐19). Coronavirus Disease 2019 (COVID‐19)
182
232
.
H.E. Groves, U. Allen & S.K. Morris. 2023. Clinical Management of Pediatric COVID-19. Clinical Management of Pediatric COVID-19
99
139
.
Milena Soriano Marcolino, Karina Cardoso Meira, Nathalia Sernizon Guimarães, Paula Perdigão Motta, Victor Schulthais Chagas, Silvana Márcia Bruschi Kelles, Laura Caetano de Sá, Reginaldo Aparecido Valacio & Patrícia Klarmann Ziegelmann. (2022) Systematic review and meta-analysis of ivermectin for treatment of COVID-19: evidence beyond the hype. BMC Infectious Diseases 22:1.
Crossref
Crossref
Angie de los Milagros Farfán-Castillo, Rosangela Simone Moreno-Núñez, Fátima Milagros Zárate-Yuyes, Lissett Jeanette Fernández-Rodríguez & Victor Hugo Bardales-Zuta. (2022) Use of Ivermectin and Chlorine Dioxide for COVID-19 Treatment and Prophylaxis in Peru: A Narrative Review. Cureus.
Crossref
Crossref
Jakob Ohlhorst. (2022) Is There a Problem of Demarcation for Hinges?. International Journal for the Study of Skepticism 12:4, pages 317-330.
Crossref
Crossref
Leon Di Stefano, Elizabeth L. Ogburn, Malathi Ram, Daniel O. Scharfstein, Tianjing Li, Preeti Khanal, Sheriza N. Baksh, Nichol McBee, Joshua Gruber, Marianne R. Gildea, Megan R. Clark, Neil A. Goldenberg, Yussef Bennani, Samuel M. Brown, Whitney R. Buckel, Meredith E. Clement, Mark J. Mulligan, Jane A. O’Halloran, Adriana M. Rauseo, Wesley H. Self, Matthew W. Semler, Todd Seto, Jason E. Stout, Robert J. Ulrich, Jennifer Victory, Barbara E. Bierer, Daniel F. Hanley & Daniel Freilich. (2022) Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysis. PLOS ONE 17:9, pages e0273526.
Crossref
Crossref
Anan Manomaipiboon, Kittisak Pholtawornkulchai, Sujaree Poopipatpab, Swangjit Suraamornkul, Jakravoot Maneerit, Wiroj Ruksakul, Uraporn Phumisantiphong & Thananda Trakarnvanich. (2022) Efficacy and safety of ivermectin in the treatment of mild to moderate COVID-19 infection: a randomized, double-blind, placebo-controlled trial. Trials 23:1.
Crossref
Crossref
Srilatha Sakamuru, Ruili Huang & Menghang Xia. (2022) Use of Tox21 Screening Data to Evaluate the COVID-19 Drug Candidates for Their Potential Toxic Effects and Related Pathways. Frontiers in Pharmacology 13.
Crossref
Crossref
Estefanía Calvo-Alvarez, Maria Dolci, Federica Perego, Lucia Signorini, Silvia Parapini, Sarah D’Alessandro, Luca Denti, Nicoletta Basilico, Donatella Taramelli, Pasquale Ferrante & Serena Delbue. (2022) Antiparasitic Drugs against SARS-CoV-2: A Comprehensive Literature Survey. Microorganisms 10:7, pages 1284.
Crossref
Crossref
Maria Popp, Stefanie Reis, Selina Schießer, Renate Ilona Hausinger, Miriam Stegemann, Maria-Inti Metzendorf, Peter Kranke, Patrick Meybohm, Nicole Skoetz & Stephanie Weibel. (2022) Ivermectin for preventing and treating COVID-19. Cochrane Database of Systematic Reviews 2022:6.
Crossref
Crossref
Thamil Vaani Komarasamy, Nur Amelia Azreen Adnan, William James & Vinod RMT Balasubramaniam. (2022) Finding a chink in the armor: Update, limitations, and challenges toward successful antivirals against flaviviruses. PLOS Neglected Tropical Diseases 16:4, pages e0010291.
Crossref
Crossref
Océane Delandre, Mathieu Gendrot, Priscilla Jardot, Marion Le Bideau, Manon Boxberger, Céline Boschi, Isabelle Fonta, Joel Mosnier, Sébastien Hutter, Anthony Levasseur, Bernard La Scola & Bruno Pradines. (2022) Antiviral Activity of Repurposing Ivermectin against a Panel of 30 Clinical SARS-CoV-2 Strains Belonging to 14 Variants. Pharmaceuticals 15:4, pages 445.
Crossref
Crossref
Ana C. Puhl, Thomas R. Lane, Fabio Urbina & Sean Ekins. (2022) The Need for Speed and Efficiency: A Brief Review of Small Molecule Antivirals for COVID-19. Frontiers in Drug Discovery 2.
Crossref
Crossref
Michal Pastorek, Martin Dúbrava & Peter Celec. (2022) On the Origin of Neutrophil Extracellular Traps in COVID-19. Frontiers in Immunology 13.
Crossref
Crossref
Warerat Kaewduangduen, Peerapat Visitchanakun, Wilasinee Saisorn, Ariya Phawadee, Charintorn Manonitnantawat, Chirapas Chutimaskul, Paweena Susantitaphong, Patcharee Ritprajak, Naraporn Somboonna, Thanya Cheibchalard, Dhammika Leshan Wannigama, Patipark Kueanjinda & Asada Leelahavanichkul. (2022) Blood Bacteria-Free DNA in Septic Mice Enhances LPS-Induced Inflammation in Mice through Macrophage Response. International Journal of Molecular Sciences 23:3, pages 1907.
Crossref
Crossref
Alessia Alunno, Aurélie Najm, Pedro M Machado, Heidi Bertheussen, Gerd-Rüdiger R Burmester, Francesco Carubbi, Gabriele De Marco, Roberto Giacomelli, Olivier Hermine, John D Isaacs, Isabelle Koné-Paut, César Magro-Checa, Iain B McInnes, Pier Luigi Meroni, Luca Quartuccio, A V Ramanan, Manuel Ramos-Casals, Javier Rodríguez Carrio, Hendrik Schulze-Koops, Tanja A Stamm, Sander W Tas, Benjamin Terrier, Dennis G McGonagle & Xavier Mariette. (2022) 2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19. Annals of the Rheumatic Diseases 81:1, pages 34-40.
Crossref
Crossref
Nirmeen Sabry, Yasser Fouad, Mohamed AbdAllah, Ahmed Cordie & Gamal Esmat. (2022) Dose-Dependent Ivermectin Effect on COVID-19 Polymerase Chain Reaction Status. American Journal of Therapeutics Publish Ahead of Print.
Crossref
Crossref
Steven G. Rothrock, Kurt D. Weber, Philip A. Giordano & Mitchell D. Barneck. (2022) Meta-Analyses Do Not Establish Improved Mortality With Ivermectin Use in COVID-19. American Journal of Therapeutics 29:2, pages e237-e244.
Crossref
Crossref
Steven G. Rothrock, Kurt D. Weber, Philip A. Giordano & Mitchell D. Barneck. (2022) Meta-Analyses Do Not Establish Improved Mortality With Ivermectin Use in COVID-19. American Journal of Therapeutics 29:1, pages e87-e94.
Crossref
Crossref
J Deng, F Zhou, S Ali, K Heybati, W Hou, E Huang & C Y Wong. (2021) Efficacy and safety of ivermectin for the treatment of COVID-19: a systematic review and meta-analysis. QJM: An International Journal of Medicine 114:10, pages 721-732.
Crossref
Crossref
Lennox Chitsike & Penelope Duerksen-Hughes. (2021) Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics. Virology Journal 18:1.
Crossref
Crossref
A G Boven, C Kenyon & R Colebunders. (2021) Ivermectin Should Not Be Recommended to Treat Severe Acute Respiratory Syndrome 2 Infection. Open Forum Infectious Diseases 8:12.
Crossref
Crossref
Debellemanière Guillaume, Bouvet Magalie, Elahi Sina, Salah-Mabed Imène, Vayr Frédéric, Dubois Mathieu, Muselier Aurore, Gozlan Yoni, Elbaz Emma, Badatcheff Charlotte, Fabre Laura, Saad Alain, Nahaisi Steven, Zeboulon Pierre, Febbraro Jean-Luc, Courtin Romain, Grise-Dulac Alice, Mazharian Adrien, Ghazal Wassim, Remongin Pierre-Emmanuel, Panthier Christophe, Chirouze Catherine, Bertrand Kevin, Sené Thomas & Gatinel Damien. (2021) Antirheumatic Drug Intake Influence on Occurrence of COVID-19 Infection in Ambulatory Patients with Immune-Mediated Inflammatory Diseases: A Cohort Study. Rheumatology and Therapy 8:4, pages 1887-1895.
Crossref
Crossref
Matteo Bassetti, Daniele Roberto Giacobbe, Paolo Bruzzi, Emanuela Barisione, Stefano Centanni, Nadia Castaldo, Silvia Corcione, Francesco Giuseppe De Rosa, Fabiano Di Marco, Andrea Gori, Andrea Gramegna, Guido Granata, Angelo Gratarola, Alberto Enrico Maraolo, Malgorzata Mikulska, Andrea Lombardi, Federico Pea, Nicola Petrosillo, Dejan Radovanovic, Pierachille Santus, Alessio Signori, Emanuela Sozio, Elena Tagliabue, Carlo Tascini, Carlo Vancheri, Antonio Vena, Pierluigi Viale, Francesco Blasi, Matteo Bassetti, Daniele Roberto Giacobbe, Paolo Bruzzi, Emanuela Barisione, Stefano Centanni, Nadia Castaldo, Silvia Corcione, Francesco Giuseppe De Rosa, Fabiano Di Marco, Andrea Gori, Andrea Gramegna, Guido Granata, Angelo Gratarola, Alberto Enrico Maraolo, Malgorzata Mikulska, Andrea Lombardi, Federico Pea, Nicola Petrosillo, Dejan Radovanovic, Pierachille Santus, Alessio Signori, Emanuela Sozio, Elena Tagliabue, Carlo Tascini, Carlo Vancheri, Antonio Vena, Pierluigi Viale & Francesco Blasi. (2021) Clinical Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP). Infectious Diseases and Therapy 10:4, pages 1837-1885.
Crossref
Crossref
Emna Harigua-Souiai, Mohamed Mahmoud Heinhane, Yosser Zina Abdelkrim, Oussama Souiai, Ines Abdeljaoued-Tej & Ikram Guizani. (2021) Deep Learning Algorithms Achieved Satisfactory Predictions When Trained on a Novel Collection of Anticoronavirus Molecules. Frontiers in Genetics 12.
Crossref
Crossref
Francesco Robert Burkert, Lukas Lanser, Rosa Bellmann-Weiler & Günter Weiss. (2021) Coronavirus Disease 2019: Clinics, Treatment, and Prevention. Frontiers in Microbiology 12.
Crossref
Crossref
Andrew Hill, Anna Garratt, Jacob Levi, Jonathan Falconer, Leah Ellis, Kaitlyn McCann, Victoria Pilkington, Ambar Qavi, Junzheng Wang & Hannah Wentzel. (2021) Retracted: Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection. Open Forum Infectious Diseases 8:11.
Crossref
Crossref
Alessia Alunno, Aurélie Najm, Xavier Mariette, Gabriele De Marco, Jenny Emmel, Laura Mason, Dennis G McGonagle & Pedro M Machado. (2021) Immunomodulatory therapies for the treatment of SARS-CoV-2 infection: an update of the systematic literature review to inform EULAR points to consider. RMD Open 7:3, pages e001899.
Crossref
Crossref
Sherief Abd‐Elsalam, Rasha A. Noor, Rehab Badawi, Mai Khalaf, Eslam S. Esmail, Shaimaa Soliman, Mohamed S. Abd El Ghafar, Mohamed Elbahnasawy, Ehab F. Moustafa, Sahar M. Hassany, Mohammed A. Medhat, Haidi Karam‐Allah Ramadan, Maii A. S. Eldeen, Mohamed Alboraie, Ahmed Cordie & Gamal Esmat. (2021) Clinical study evaluating the efficacy of ivermectin in COVID‐19 treatment: A randomized controlled study. Journal of Medical Virology 93:10, pages 5833-5838.
Crossref
Crossref
Chenyang Zhang, Huaqing Jin, Yi Feng Wen & Guosheng Yin. (2021) Efficacy of COVID-19 Treatments: A Bayesian Network Meta-Analysis of Randomized Controlled Trials. Frontiers in Public Health 9.
Crossref
Crossref
A.D. Santin, D.E. Scheim, P.A. McCullough, M. Yagisawa & T.J. Borody. (2021) Ivermectin: a multifaceted drug of Nobel prize-honoured distinction with indicated efficacy against a new global scourge, COVID-19. New Microbes and New Infections 43, pages 100924.
Crossref
Crossref
Rohit KumarAnkit MittalShreya Das AdhikariEram AfrozNitin Gupta. (2021) India and management of COVID-19: A case study on published guidelines. Drug Discoveries & Therapeutics 15:4, pages 171-179.
Crossref
Crossref
Maria Popp, Miriam Stegemann, Maria-Inti Metzendorf, Susan Gould, Peter Kranke, Patrick Meybohm, Nicole Skoetz & Stephanie Weibel. (2021) Ivermectin for preventing and treating COVID-19. Cochrane Database of Systematic Reviews 2021:10.
Crossref
Crossref
Bruno Ramalho de Carvalho. (2021) COVID-19 in Brazil: A Message to the World. Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics 43:03, pages 238-239.
Crossref
Crossref
Alok Singh, PranavG Sheth, Suryaprakash Dhaneria & Dhyuti Gupta. (2021) Efficacy and safety of ivermectin for COVID-19: A systematic review and meta-analysis. Asian Pacific Journal of Tropical Medicine 14:10, pages 440.
Crossref
Crossref
Chia Siang Kow & Syed S. Hasan. (2021) Pitfalls in Reporting Sample Size Calculation Across Randomized Controlled Trials Involving Ivermectin for the treatment of COVID-19. American Journal of Therapeutics 28:5, pages e616-e619.
Crossref
Crossref
Milena Soriano Marcolino, Karina Cardoso Meira, Victor Schulthais Chagas, Nathalia Sernizon Guimarães, Paula Perdigão Motta, Silvana Márcia Bruschi Kelles, Laura Caetano de Sá, Reginaldo Aparecido Valacio & Patricia K. Ziegelmann. (2022) Systematic Review and Meta-Analysis of Ivermectin for Treatment of COVID-19: Evidence Beyond the Hype. SSRN Electronic Journal.
Crossref
Crossref